Answers from the Lab Por: Mayo Clinic Laboratories A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes. 372 episodios disponibles Latest episodes of the podcast Answers from the Lab Mostrando página 4 de 19 Scaling Knowledge With AI: Bill Morice, M.D., Ph.D. 18/07/2024 An Impactful Supreme Court Decision: Bill Morice, M.D., Ph.D. 11/07/2024 The Metals Laboratory Tests Beethoven’s Hair: Paul Jannetto, Ph.D. 04/07/2024 COVID-19 and Avian Flu: Bill Morice, M.D., Ph.D. 27/06/2024 The Platform Transformation of Healthcare: Bill Morice, M.D., Ph.D. 13/06/2024 Updates Streamline Autoimmune Neurology Testing: Anastasia Zekeridou, M.D., Ph.D. 11/06/2024 Infectious Diseases on the Move: Bill Morice, M.D., Ph.D. 06/06/2024 Tests Aid Diagnosis of Cancer-Associated Neurological Disorders: Divyanshu Dubey, M.B.B.S. 04/06/2024 Get to Know DLMP’s Vice Chair of Research: Peter Lucas, M.D., Ph.D. 30/05/2024 Avian Flu Outbreaks and New COVID-19 Variants: Matthew Binnicker, Ph.D. 23/05/2024 Enhanced Solid Tumor NGS Panel Broadens Genetic-Variants Detection: Robert Jenkins, M.D., Ph.D., Stephanie Smoley, CG(ASCP), and Beth Pitel, M.S. 21/05/2024 New Panels Help Find Cause of Rapidly Progressive Dementia: Gregory (Gregg) Day, M.D. 14/05/2024 Get to Know the DLMP Chair: Eric Hsi, M.D. 09/05/2024 Oral fluid offers an alternative specimen for controlled substance monitoring: Paul Jannetto, Ph.D. 07/05/2024 FDA Issues Final Rule to Regulate LDTs: Bill Morice, M.D., Ph.D. 02/05/2024 The Growing Crisis of Antimicrobial Resistance: Robin Patel, M.D. 02/05/2024 Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D. 30/04/2024 Alzheimer’s Disease and Testing Innovations: Bill Morice, M.D., Ph.D. 25/04/2024 Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D 23/04/2024 Lab Week and Noteworthy News: Bill Morice, M.D., Ph.D. 18/04/2024 « Primera ‹ Anterior 1 2 3 4 5 6 ... 19 Siguiente › Última » Share Facebook Twitter LinkedIn